Michael Gelband’s Eagle Nuclear Energy Corp NUCL Stock Holding History

Michael Gelband’s Portfolio NUCL Stock Details NUCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,558	Closed	-$219K	–	2223
2026 Q1	$219K	Buy	+28,558	New	+$169K	﹤0.01%	1365

Other funds holding NUCL

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vident Advisory Alpharetta, Georgia $13.9B AUM 53.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Michael Gelband's NUCL Position: Q2 2026 in Review

Michael Gelband sold out of Eagle Nuclear Energy Corp (NUCL) in Q2 2026, closing a stake of 28,558 shares — an estimated $219K sold.

Michael Gelband first reported a position in NUCL in Q1 2026 and held it in 1 quarter. The position peaked at $219K in Q1 2026. 40 funds tracked by Wall St. Rank hold NUCL as of Q2 2026.

Michael Gelband reported no remaining Eagle Nuclear Energy Corp position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 28,558 Eagle Nuclear Energy Corp shares in Q2 2026, an estimated $219K.
Michael Gelband first reported a position in Eagle Nuclear Energy Corp in Q1 2026 and held it in 1 quarter.
Michael Gelband's Eagle Nuclear Energy Corp position peaked at $219K in Q1 2026.
40 funds tracked by Wall St. Rank held Eagle Nuclear Energy Corp as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.